Plastic pleurisy is a medical condition characterized by inflammation of the pleural membranes that line the lungs. The pleura is a thin, double-layered membrane that surrounds the lungs, allowing them to expand and contract during breathing. In plastic pleurisy, there is an excessive accumulation of fibrin or other partly fibrinous products in the pleural cavity, causing the pleural membranes to become inflamed and thickened.
This condition is often associated with other underlying health issues, such as tuberculosis, pneumonia, lung abscess, rheumatoid arthritis, or systemic lupus erythematosus. It typically presents with symptoms such as persistent chest pain that worsens with deep breathing or coughing, shortness of breath, cough, and general malaise.
Diagnosis of plastic pleurisy involves a thorough physical examination, medical history assessment, and diagnostic tests such as chest X-rays, computed tomography (CT) scan, or ultrasound to visualize the pleura and assess the extent of inflammation.
Treatment for plastic pleurisy aims to alleviate symptoms, address the underlying cause, and reduce inflammation. This often involves pharmacological intervention with nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, or corticosteroids to relieve pain and reduce inflammation. Antibiotics may be prescribed if an infection is present. In severe cases, drainage of fluid from the pleural cavity may be necessary to relieve pressure and facilitate healing.
Overall, plastic pleurisy is a condition characterized by inflammation and thickening of the pleural membranes, usually due to an underlying health issue. Prompt diagnosis and appropriate treatment are crucial in managing and resolving symptoms.
